Healthcare provider profile · identity verified

Carlene Auguste

Nurse Practitioner · FRESH MEADOWS, NY · NPI 1669079950

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	371	133
Amlodipine Besylate	Amlodipine Besylate	289	107
Albuterol Sulfate Hfa	Albuterol Sulfate	248	47
Pantoprazole Sodium	Pantoprazole Sodium	186	55
Losartan Potassium	Losartan Potassium	132	48
Lisinopril	Lisinopril	125	47
Metoprolol Succinate	Metoprolol Succinate	118	38
Alcohol Prep Pads	Alcohol Antiseptic Pads	106	38
Hydrochlorothiazide	Hydrochlorothiazide	105	39
Tamsulosin Hcl	Tamsulosin Hcl	102	37
Gabapentin	Gabapentin	100	29
Latanoprost	Latanoprost	98	27
Levothyroxine Sodium	Levothyroxine Sodium	97	23
Metformin Hcl Er	Metformin Hcl	94	45
Furosemide	Furosemide	80	24
Januvia	Sitagliptin Phosphate	79	23
Ammonium Lactate	Ammonium Lactate	78	22
Simvastatin	Simvastatin	78	22
Metformin Hcl	Metformin Hcl	73	26
Diclofenac Sodium	Diclofenac Sodium	71	27
Famotidine	Famotidine	70	28
Fluticasone Propionate	Fluticasone Propionate	63	23
Hydralazine Hcl	Hydralazine Hcl	59	20
Metoprolol Tartrate	Metoprolol Tartrate	58	16
Eliquis	Apixaban	55	17
Jardiance	Empagliflozin	47	16
Montelukast Sodium	Montelukast Sodium	46	18
Rosuvastatin Calcium	Rosuvastatin Calcium	45	19
Omeprazole	Omeprazole	44	17
Vitamin D2	Ergocalciferol (Vitamin D2)	40	16
Ibuprofen	Ibuprofen	39	19
Brimonidine Tartrate	Brimonidine Tartrate	37	suppressed
Carvedilol	Carvedilol	34	suppressed
Finasteride	Finasteride	33	14
Single Use Swab	Alcohol Antiseptic Pads	33	22
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	32	suppressed
Symbicort	Budesonide/Formoterol Fumarate	31	suppressed
Hydrocortisone	Hydrocortisone	30	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	16
Glipizide	Glipizide	27	suppressed
Meclizine Hcl	Meclizine Hcl	27	12
Meloxicam	Meloxicam	27	suppressed
Nifedipine Er	Nifedipine	24	suppressed
Trulicity	Dulaglutide	24	suppressed
Clonidine Hcl	Clonidine Hcl	23	suppressed
Clotrimazole	Clotrimazole	23	12
Triamcinolone Acetonide	Triamcinolone Acetonide	23	12
Escitalopram Oxalate	Escitalopram Oxalate	22	suppressed
Potassium Chloride	Potassium Chloride	22	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Entresto	Sacubitril/Valsartan	20	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	20	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	19	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Lactulose	Lactulose	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Ketoconazole	Ketoconazole	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Clopidogrel	Clopidogrel Bisulfate	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Pravastatin Sodium	Pravastatin Sodium	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Torsemide	Torsemide	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Pentoxifylline	Pentoxifylline	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Atrovent Hfa	Ipratropium Bromide	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Ibu	Ibuprofen	11	suppressed
Ozempic	Semaglutide	11	suppressed
Trazodone Hcl	Trazodone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error